The short answer
Ginger may affect platelet function, but it is uncertain whether it adds a meaningful bleeding risk to aspirin. Review concentrated ginger products with your pharmacist, particularly if you also take another medicine that affects bleeding. The evidence does not justify treating every ginger preparation as equivalent.
What this answer covers
This concerns oral Zingiber officinale, commonly called ginger. Dried powder, fresh ginger, tea and extracts have different study evidence. A report involving ginger extract and several other products cannot establish the effect of all products from this species.
- Supplement or preparation
- Zingiber Officinale
- Medication ingredient
- aspirin
What have human platelet studies found?
Results vary. A small placebo comparison found no effect after 2 g of dried ginger. In heart-disease patients, 4 g of powder daily for three months did not change the measured platelet responses, while a separate 10 g dose did. These are study exposures, not safe-dose limits, and platelet changes do not establish clinical bleeding.
Has bleeding been reported in someone taking aspirin?
One man with gum bleeding and bruising was taking aspirin 100 mg daily, clopidogrel 75 mg daily, ginger extract and several other supplements. Bleeding resolved after several changes. The report could not identify ginger as the cause or determine its contribution, and it did not test plain ginger powder.
Do larger studies resolve the uncertainty?
An observational study did not establish extra major-bleeding admissions with prescribed ginger-containing Chinese medicines. However, it combined different antiplatelet drugs and often involved herbal mixtures. Its estimates were imprecise, so it neither proves an aspirin-specific interaction nor guarantees that a ginger supplement is safe.
What does current guidance say?
The current European ginger monograph lists no known medicine interactions for the preparations it covers. That reflects limited and inconsistent evidence, rather than certainty about every extract or retail supplement. Show your pharmacist the actual product and daily amount, along with your full medicine list, before deciding whether to use it.
What should prompt medical help?
Aspirin itself can cause serious bleeding. Seek urgent care for vomiting blood, black or bloody stools, or faintness with suspected bleeding. Tell the clinician about ginger and all other supplements. Keep routine changes to prescribed aspirin under its prescriber’s guidance rather than changing it to make room for ginger.
Evidence and practical considerations
Physiologic interactions
Human ginger platelet-test findings are mixed and do not establish a clinical bleeding interaction with aspirin.
- Exact scope
- Dried ginger and powder regimens, not interchangeable with every extract. with Aspirin, exact RxCUI 1191, inventory name aspirin, TTY IN; oral aspirin only. Acetylsalicylic acid and ASA in the original reports denote aspirin. The 81 mg delayed-release label provides medication safety context; directly studied 100 mg daily regimens are identified separately. No other antiplatelet, anticoagulant, NSAID, route or salicylate is substituted for aspirin.
- Medication form and route
- oral
What remains uncertain
- Small heterogeneous studies, different doses and laboratory endpoints; original aspirin coexposure not verified in Bordia abstract.
Read the supporting source summaries
Source 1: original human clinical study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Eight healthy male volunteers in a randomized blinded placebo comparison.
No detected difference in bleeding time, platelet count, thromboelastography or whole-blood platelet aggregation.
How this applies: Contrary human dried-ginger evidence; not direct aspirin-pair evidence or proof that dose separation works.
Very small, short study. Does not establish a safe dose, long-term effect or aspirin interaction. Only the original abstract was accessible.
Source 2: original human clinical study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Coronary artery disease participants in the ginger portions of a placebo-controlled study. Original abstract does not provide subgroup counts or aspirin co-medication details.
The repeated 4 g regimen did not change the measured platelet aggregation responses; the single 10 g exposure reduced aggregation. Clinical bleeding was not established.
How this applies: Exact-species powdered-ginger human findings with mixed laboratory results. Aspirin use stated by later government guidance remains secondary, not silently upgraded to original verification.
No verified original aspirin dose or coexposure detail; cannot treat this as an inspected aspirin combination trial. Platelet tests are surrogate endpoints, and these doses are not a safe-use threshold.
Source 3: original human clinical study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Twenty healthy men after seven days of a diet supplemented with 100 g butter; ten received ginger and ten placebo.
Ginger reduced ADP- and epinephrine-induced platelet aggregation in this dietary setting; placebo did not show a significant change.
How this applies: Positive ginger-only platelet signal balancing null studies; does not prove increased aspirin-related bleeding.
Small study, dietary challenge, surrogate endpoint, no aspirin combination and no clinical bleeding result. Further duration and product standardization unavailable in abstract.
Research assessment: · Open full citations ↗
Side effects & toxicity
An aspirin-containing polypharmacy case raises concern, but an exact ginger-aspirin bleeding effect remains uncertain.
- Exact scope
- Unspecified ginger extract in one case; prescribed ginger-containing mixtures in the observational study. with Aspirin, exact RxCUI 1191, inventory name aspirin, TTY IN; oral aspirin only. Acetylsalicylic acid and ASA in the original reports denote aspirin. The 81 mg delayed-release label provides medication safety context; directly studied 100 mg daily regimens are identified separately. No other antiplatelet, anticoagulant, NSAID, route or salicylate is substituted for aspirin.
- Medication form and route
- oral
What remains uncertain
- Clopidogrel, other supplements and simultaneous changes confound the case; pooled-drug observational estimates do not isolate aspirin.
Read the supporting source summaries
Source 1: original human case report
dovepress.com · Source check Sep 10, 2026
Population: One 65-year-old man with cardiovascular disease, diabetes and multiple prescriptions.
Gum bleeding and bruising resolved after several supplements were stopped or reduced and other treatment changes occurred.
How this applies: Aspirin-containing regimen and ginger-extract warning signal, not proof of causation by ginger alone or evidence for root powder.
No rechallenge or isolated ginger withdrawal. Contribution of each exposure cannot be determined. Authors disclosed involvement with the interaction software used.
Source 2: original population-based observational study
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Taiwan claims cohort of 79,463 antiplatelet users; 1,209 first major-bleeding admissions entered the case-crossover analysis.
Ginger-containing exposures showed no statistically established association with hospitalization: adjusted odds ratios 0.84 (95% CI 0.19-3.73) and 0.72 (0.25-2.08) against two reference periods.
How this applies: Indirect clinical-outcome context; pooled antiplatelet estimates cannot be relabeled aspirin-only or plain powder estimates.
Wide intervals, few herb-exposed cases, mixtures and prescription records; retail intake unmeasured. Neither absence of harm nor a protective effect is established.
Research assessment: · Open full citations ↗
Timing & monitoring
Review ginger product identity and overall bleeding risk; current evidence and the EU monograph do not support a universal interaction magnitude or blanket safety assurance.
- Exact scope
- Specified medicinal rhizome products and separately assessed retail preparations. with Aspirin, exact RxCUI 1191, inventory name aspirin, TTY IN; oral aspirin only. Acetylsalicylic acid and ASA in the original reports denote aspirin. The 81 mg delayed-release label provides medication safety context; directly studied 100 mg daily regimens are identified separately. No other antiplatelet, anticoagulant, NSAID, route or salicylate is substituted for aspirin.
- Medication form and route
- oral
What remains uncertain
- Clinical precaution based on uncertainty and aspirin labeling, not a proven universal herb interaction.
Read the supporting source summaries
Source 1: government herbal medicinal-product monograph
ema.europa.eu · Source check Sep 10, 2026
Population: Users of medicinal ginger preparations within the monograph, with indication- and age-specific restrictions.
Lists no known medicinal-product interactions and supplies no aspirin-specific separation interval.
How this applies: Defines the rhizome/powder boundary and provides contrary context to blanket avoidance or timing claims.
A regulatory assessment of available evidence, not a controlled aspirin-powder trial or guarantee of safety for unstudied products.
Source 2: government clinical and nonclinical evidence assessment
ema.europa.eu · Source check Sep 10, 2026
Population: Evidence covering ginger medicinal preparations, human platelet tests and reports with anticoagulants.
Assessors found studies small and inconsistent and evidence insufficient for a general hemorrhage or anticoagulant-interaction warning in the monograph.
How this applies: Supports accurately describing uncertainty and the absence of an established aspirin spacing rule, with no class transfer.
Historical national cautions, including a 14-day anticoagulant monitoring statement, are quoted separately and are not the final EU conclusion. Anticoagulant reports do not establish aspirin effects.
Source 3: regulatory OTC drug labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People considering or taking the labeled oral aspirin product.
Warns of severe stomach bleeding. Prior bleeding or ulcers, older age, anticoagulants, other NSAIDs, steroids, heavy alcohol use and excessive dosing increase concern. Blood in vomit or stool, black stool and faintness warrant medical attention.
How this applies: Medication-only safety context and warning signs, not proof of a botanical interaction.
The label does not name ginger or turmeric and does not measure either added interaction risk.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original evidence and current product information inspected, with distinctions between laboratory findings, clinical outcomes and preparation-specific limits. | |
| Research summary published |
Article revision: c90336654c214ed1
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.